Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.
Pitisuttithum P, Berman PW, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai LO, Hirunras K, Kitayaporn D, Kaewkangwal J, Migasena S, Sheppard HW, Li E, Chernow M, Peterson ML, Shibata R, Heyward WL, Francis DP. Pitisuttithum P, et al. Among authors: shibata r. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1160-5. doi: 10.1097/01.qai.0000136091.72955.4b. J Acquir Immune Defic Syndr. 2004. PMID: 15319676 Clinical Trial.
[Development of HIV vaccines].
Shibata R. Shibata R. Nihon Rinsho. 2002 Apr;60(4):790-7. Nihon Rinsho. 2002. PMID: 11968790 Review. Japanese.
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies.
Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Plishka RJ, Buckler-White A, Shibata R, Martin MA. Nishimura Y, et al. Among authors: shibata r. J Virol. 2002 Mar;76(5):2123-30. doi: 10.1128/jvi.76.5.2123-2130.2002. J Virol. 2002. PMID: 11836389 Free PMC article.
We previously reported that high-titered neutralizing antibodies directed against the human immunodeficiency virus type 1 (HIV-1) envelope can block the establishment of a simian immunodeficiency virus (SIV)/HIV chimeric virus (SHIV) infection in two monkeys following passive tra …
We previously reported that high-titered neutralizing antibodies directed against the human immunodeficiency virus type 1 (HIV-1) envelope c …
Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.
Igarashi T, Endo Y, Englund G, Sadjadpour R, Matano T, Buckler C, Buckler-White A, Plishka R, Theodore T, Shibata R, Martin M. Igarashi T, et al. Among authors: shibata r. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14049-54. doi: 10.1073/pnas.96.24.14049. Proc Natl Acad Sci U S A. 1999. PMID: 10570196 Free PMC article.
600 results